Literature DB >> 17320811

Methicillin-resistant Staphylococcus aureus infectious keratitis following refractive surgery.

Renée Solomon1, Eric D Donnenfeld, Henry D Perry, Roy S Rubinfeld, Michael Ehrenhaus, John R Wittpenn, Kerry D Solomon, Edward E Manche, Majid Moshirfar, Dennis C Matzkin, Reza M Mozayeni, Robert K Maloney.   

Abstract

PURPOSE: To elucidate risk factors, clinical course, visual outcomes, and treatment of culture-proven methicillin-resistant Staphylococcus aureus (MRSA) infectious keratitis following refractive surgery.
DESIGN: Interventional case series.
METHODS: Multicenter chart review of 13 cases of MRSA keratitis following refractive surgery and literature review.
RESULTS: Thirteen eyes of 12 patients, nine of whom were either healthcare workers or exposed to a hospital surgical setting, developed MRSA keratitis following refractive surgery. All patients presented with a decrease in visual acuity and complaints of pain or irritation in the affected eye. Common signs on slit-lamp biomicroscopy were corneal epithelial defects, focal infiltrates with surrounding edema, conjunctival injection, purulent discharge, and hypopyon. All patients were diagnosed with infectious keratitis on presentation and treated with two antibiotics. All eyes were culture-positive for MRSA.
CONCLUSIONS: According to a computerized MEDLINE literature search, this is the first case series of MRSA infectious keratitis following refractive surgery, the first reports of MRSA keratitis after refractive surgery in patients with no known exposure to a healthcare facility, the first report of MRSA keratitis after a laser in situ keratomileusis (LASIK) enhancement, and the first reports of MRSA keratitis after prophylaxis with fourth-generation fluoroquinolones. MRSA keratitis is a serious and increasing complication following refractive surgery. Patients with exposure to a healthcare environment should be considered at additional risk for developing MRSA keratitis. However, in addition, surgeons should now be vigilant for community-acquired MRSA. Prompt identification with culturing and appropriate treatment of MRSA keratitis after refractive surgery is important to improve visual rehabilitation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17320811     DOI: 10.1016/j.ajo.2006.12.029

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  21 in total

1.  [Epidemiology of and preventive measures for multiresistant pathogens].

Authors:  E-B Kruse; M Dettenkofer
Journal:  Ophthalmologe       Date:  2010-04       Impact factor: 1.059

2.  [Multiresistant bacteria in ophthalmology].

Authors:  T Ness
Journal:  Ophthalmologe       Date:  2010-04       Impact factor: 1.059

3.  Staphylolysin is an effective therapeutic agent for Staphylococcus aureus experimental keratitis.

Authors:  Irina S Barequet; Nirit Bourla; Yuval N Pessach; Mary Safrin; Dalit Yankovich; Dennis E Ohman; Mordechai Rosner; Efrat Kessler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-09-24       Impact factor: 3.117

4.  Efficacy and tolerability of a fixed-dose moxifloxacin - dexamethasone formulation for topical prophylaxis in LASIK: a comparative, double-masked clinical trial.

Authors:  Mauro Campos; Mariana Avila; Anelise Wallau; Cristina Muccioli; Ana Luisa Höfling-Lima; Rubens Belfort
Journal:  Clin Ophthalmol       Date:  2008-06

5.  What is Central Toxic Keratopathy Syndrome if it is not Diffuse lamellar Keratitis Grade IV?

Authors:  Ribhi Hazin; Yassine J Daoud; Yousuf M Khalifa
Journal:  Middle East Afr J Ophthalmol       Date:  2010-01

6.  Two cases of methicillin-resistant Staphylococcus aureus keratitis after Epi-LASIK.

Authors:  Norimasa Nomi; Naoyuki Morishige; Naoyuki Yamada; Tai-Ichiro Chikama; Teruo Nishida
Journal:  Jpn J Ophthalmol       Date:  2008-12-17       Impact factor: 2.447

7.  Postantibiotic effects and bactericidal activities of levofloxacin and gatifloxacin at concentrations simulating those of topical ophthalmic administration against fluoroquinolone-resistant and fluoroquinolone-sensitive methicillin-resistant Staphylococcus aureus strains.

Authors:  Saichi Hoshi; Ken Kikuchi; Takashi Sasaki; Chie Sotozono; Shigeru Kinoshita; Keiichi Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2008-05-19       Impact factor: 5.191

Review 8.  LASIK interface complications: etiology, management, and outcomes.

Authors:  J Bradley Randleman; Rupa D Shah
Journal:  J Refract Surg       Date:  2012-08       Impact factor: 3.573

9.  Staphylococcus aureus ocular infection: methicillin-resistance, clinical features, and antibiotic susceptibilities.

Authors:  Chih-Chun Chuang; Ching-Hsi Hsiao; Hsin-Yuan Tan; David Hui-Kang Ma; Ken-Kuo Lin; Chee-Jen Chang; Yhu-Chering Huang
Journal:  PLoS One       Date:  2012-08-07       Impact factor: 3.240

10.  Safety of besifloxacin ophthalmic suspension 0.6% in refractive surgery: a retrospective chart review of post-LASIK patients.

Authors:  Steven A Nielsen; Marguerite B McDonald; Parag A Majmudar
Journal:  Clin Ophthalmol       Date:  2013-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.